Below are the financial statements of Neurocrine Biosciences, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in millions of USD | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenues | — | — | — |
| Net product sales | 2,330.6a | 1,860.6a | 1,440.9a |
| Collaboration revenue | 24.7a | 26.5a | 47.8a |
| Total revenues | 2,355.3a | 1,887.1a | 1,488.7a |
| Operating expenses | — | — | — |
| Cost of revenues | -34a | -39.7a | -23.2a |
| Research and development | -731.1a | -565a | -463.8a |
| Acquired in-process research and development | -12.5a | -143.9a | 0a |
| Selling, general, and administrative | -1,007.2a | -887.6a | -752.7a |
| Total operating expenses | -1,784.8a | -1,636.2a | -1,239.7a |
| Operating income | 570.5a | 250.9a | 249a |
| Other (expense) income | — | — | — |
| Unrealized (loss) gain on equity investments | -37.1a | 28.4a | 30.8a |
| Charges associated with convertible senior notes | -138.4a | 0a | -70a |
| Interest income and other, net | 91a | 52.8a | 4.1a |
| Total other (expense) income, net | -84.5a | 81.2a | -35.1a |
| Income before provision for income taxes | 486a | 332.1a | 213.9a |
| Provision for income taxes | -144.7a | -82.4a | -59.4a |
| Net income | 341.3a | 249.7a | 154.5a |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Neurocrine Biosciences’s data sources below and access millions more through our Disclosure Search.
Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.